astr partners
Julianne Berry, Ph.D., is a seasoned professional in the biotech and pharmaceutical industries, currently serving as a Scientific Advisor at Astr Partners since July 2024. Prior experience includes roles such as Vice President of Respiratory Product Development at Odin Pharmaceuticals, where Julianne established branding and commercialization for respiratory programs, and Senior Director of Respiratory Research and Development at Glenmark Pharmaceuticals, leading the development of inhaled drug products. Throughout a distinguished career that began as a Research Fellow at Schering-Plough Research Institute, Julianne has held various positions including Principal Scientist at Merck, where significant contributions were made to the commercialization of inhaled medications like Dulera®. Julianne Berry's academic credentials include a Ph.D. in Physical Organic Chemistry from the University of California and a postdoctoral fellowship at the University of Kansas.
This person is not in the org chart
This person is not in any teams
astr partners
astr partners is building an exclusive network, purpose-built to support life science investors and their priority portfolio companies. Our strategic corporate development, capital advisory and investor access will address the needs of biotech companies in a collaborative way while ensuring their stories are in front of the top minds in the space. In support of this effort, we are also curating a network of capital outside of the biotech community interested in meeting top idea flow from specialists. astr partners, named for the corner of Astor Place and Broadway in NYC, is a seasoned team in life sciences across investor relations, banking and in-house expertise.